Table 2.
Characteristics | Wave 1 | Wave 2 | Vaccination status between HP and NHP in Wave 2 | Between Wave 1 HP and Wave 2 HP | Between Wave 1 NHP and Wave 2 NHP | Total | ||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|
HP (n=200)n (%) | NHP (n=200)n (%) | HP (n=200)n (%) | NHP (n=200)n (%) | P-values | P-values | P-values | ||||||
Infection severity | ||||||||||||
Asymptomatic | 36 | (18) | 99 | (49) | 20 | (10) | 82 | (41) | NA | 0.02 | 0.11 | 237 |
Mild/moderate | 102 | (51) | 101 | (51) | 49 | (25) | 118 | (59) | NA | 0.02 | 0.11 | 370 |
Severe/critical | 50 | (25) | 0 | (0) | 78 | (39) | 0 | (0) | NA | 0.002 | Undefined | 128 |
Died | 12 | (6) | 0 | (0) | 53 | (26) | 0 | (0) | NA | <0.0001 | Undefined | 65 |
Vaccination status | ||||||||||||
Unvaccinated | 200 | (100) | 200 | (100) | 189 | (94) | 180 | (90) | 0.14 | NA | NA | 769 |
One dose | 0 | (0) | 0 | (0) | 9 | (5) | 17 | (9) | 0.12 | NA | NA | 26 |
Two doses | 0 | (0) | 0 | (0) | 2 | (1) | 3 | (1) | 1.00 | NA | NA | 5 |
Two doses + 14 daysa | 0 | (0) | 0 | (0) | 0 | (0) | 0 | (0) | Undefined | NA | NA | 0 |
Fully vaccinated.